ECSP19088005A - OROPHARYNGEAL AEROSOL COMPOSED BY A HYDROLYZED DERIVED FROM A PROBIOTIC THAT HAS AN IMPACT ON THE IMMUNITY OF THE GENITOURINARY TRACT, METHOD OF OBTAINING THE HYDROLYZED, PHARMACEUTICAL COMPOSITIONS CONTAINING IT, AND USE OF THEM - Google Patents

OROPHARYNGEAL AEROSOL COMPOSED BY A HYDROLYZED DERIVED FROM A PROBIOTIC THAT HAS AN IMPACT ON THE IMMUNITY OF THE GENITOURINARY TRACT, METHOD OF OBTAINING THE HYDROLYZED, PHARMACEUTICAL COMPOSITIONS CONTAINING IT, AND USE OF THEM

Info

Publication number
ECSP19088005A
ECSP19088005A ECSENADI201988005A ECDI201988005A ECSP19088005A EC SP19088005 A ECSP19088005 A EC SP19088005A EC SENADI201988005 A ECSENADI201988005 A EC SENADI201988005A EC DI201988005 A ECDI201988005 A EC DI201988005A EC SP19088005 A ECSP19088005 A EC SP19088005A
Authority
EC
Ecuador
Prior art keywords
hydrolyzed
obtaining
pharmaceutical compositions
compositions containing
probiotic
Prior art date
Application number
ECSENADI201988005A
Other languages
Spanish (es)
Inventor
Inostroza Erica Castro
María José Aguayo
Juan Pablo Mellado
Margarita González
Moreno María Piderit
Yánez Rodrigo Bórquez
Arjona Valeska Aeschlimann
Original Assignee
Univ San Sebastian
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ San Sebastian filed Critical Univ San Sebastian
Publication of ECSP19088005A publication Critical patent/ECSP19088005A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Abstract

La invención desarrollada en el campo de los productos biotecnológicos naturales, describe un compuesto basado en hidrolizado proteico soluble (HPS) de la cepa probiótica Lactobacillus spp DSM32447. En particular, la invención refiere a un compuesto de origen natural, inocuo que confiere inmunidad de mucosas, se describe el método de obtención, composiciones farmacéuticas que lo contienen y uso de las mismas.The invention developed in the field of natural biotechnological products describes a compound based on soluble protein hydrolyzate (HPS) from the probiotic strain Lactobacillus spp DSM32447. In particular, the invention refers to a harmless compound of natural origin that confers mucosal immunity, the method of obtaining it, the pharmaceutical compositions containing it, and the use thereof are described.

ECSENADI201988005A 2017-05-17 2019-12-11 OROPHARYNGEAL AEROSOL COMPOSED BY A HYDROLYZED DERIVED FROM A PROBIOTIC THAT HAS AN IMPACT ON THE IMMUNITY OF THE GENITOURINARY TRACT, METHOD OF OBTAINING THE HYDROLYZED, PHARMACEUTICAL COMPOSITIONS CONTAINING IT, AND USE OF THEM ECSP19088005A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2017001273A CL2017001273A1 (en) 2017-05-17 2017-05-17 Oropharyngeal spray composed of a hydrolyzate derived from a probiotic that has an impact on the immunity of the genitourinary tract, method of obtaining the hydrolyzate, pharmaceutical compositions containing it and use thereof.

Publications (1)

Publication Number Publication Date
ECSP19088005A true ECSP19088005A (en) 2020-05-29

Family

ID=63046376

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI201988005A ECSP19088005A (en) 2017-05-17 2019-12-11 OROPHARYNGEAL AEROSOL COMPOSED BY A HYDROLYZED DERIVED FROM A PROBIOTIC THAT HAS AN IMPACT ON THE IMMUNITY OF THE GENITOURINARY TRACT, METHOD OF OBTAINING THE HYDROLYZED, PHARMACEUTICAL COMPOSITIONS CONTAINING IT, AND USE OF THEM

Country Status (4)

Country Link
AR (1) AR112354A1 (en)
CL (1) CL2017001273A1 (en)
EC (1) ECSP19088005A (en)
WO (1) WO2018209457A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109674826A (en) * 2019-01-31 2019-04-26 吉林省知遇科技有限公司 A kind of probiotic composition for nursing female reproductive system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2087094T3 (en) * 2006-11-17 2014-05-12 Sca Hygiene Prod Ab LACTOBACILLUS FERMENTUM ESS-1, DSM17851 AND ITS APPLICATION FOR THE TREATMENT AND / OR PREVENTION OF CANDIDIASIS AND URINAL INFECTIONS
EP2540818A1 (en) * 2008-09-04 2013-01-02 OM Pharma Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
CL2009001511A1 (en) * 2009-07-02 2009-10-23 Univ De Concepcion 61 02% Pharmaceutical formulation comprising viable strains of lactobacillus acidophilus lpv 31 and l. plantarum lpm-01, which is useful in the prevention and / or treatment of urinary infections and in improving the immune response in immunocompromised patients.
GB201409541D0 (en) * 2014-05-29 2014-07-16 Univ Manchester Probiotic Bacteria
EP3064072A1 (en) * 2015-02-11 2016-09-07 AB-Biotics S.A. Probiotic lactobacillus strains for use in treating urinary tract infections

Also Published As

Publication number Publication date
WO2018209457A1 (en) 2018-11-22
AR112354A1 (en) 2019-10-23
CL2017001273A1 (en) 2018-03-16

Similar Documents

Publication Publication Date Title
CO2019000135A2 (en) Compositions comprising bacterial strains
CO2019004886A2 (en) Peptides that can unfold and insecticidal and nematicidal proteins that comprise them
WO2016097409A3 (en) Lidar based on mems
DOP2016000051A (en) POLYPEPTIDE FOR THE HYDROLYTIC EXCISION OF ZEARALENONE AND / OR DERIVATIVES OF ZEARALENONE, POLYNUCLEOTIDE ISOLATED FROM THE SAME AND POLYEPTIDE CONTAINING ADDITIVE, USE AND PROCEDURE OF THE SAME.
CR20160499A (en) STABLE COMPOSITIONS OF IODINE NOT IN COMPLEX AND METHODS OF USE
CY1124425T1 (en) COMPOSITIONS COMPRISING ANTIBODY-DUCOCARMYCIN DRUG CONJUGATES
ES2722773T3 (en) Modified Meningococcal fHbp Polypeptides
BR112017009790A2 (en) anti-ang2 antibodies and methods of use
AR106481A1 (en) LIQUID DETERGENT COMPOSITION
AR101742A1 (en) CALCITONINE AND AMILINE RECEIVER AGONIST
AR120721A2 (en) PEPTIDES AND COMPOSITIONS FOR THE TREATMENT OF JOINT DAMAGE
UY36394A (en) VACCINES AGAINST DISEASE OF HANDS, FEET AND MOUTH AND MANUFACTURING METHODS AND ITS USE.
PL408649A1 (en) Influenza viruses haemagglutinin protein as the vaccine antigen
MX2019010367A (en) Aqueous anti-pd-l1 antibody formulation.
CO2017012675A2 (en) Protein resistant lipid peptides
MX2017016588A (en) Novel triterpene-glycosides as sweeteners or sweetener enhancer.
MX2018008019A (en) Peptide tag and tagged protein including same.
ECSP19088005A (en) OROPHARYNGEAL AEROSOL COMPOSED BY A HYDROLYZED DERIVED FROM A PROBIOTIC THAT HAS AN IMPACT ON THE IMMUNITY OF THE GENITOURINARY TRACT, METHOD OF OBTAINING THE HYDROLYZED, PHARMACEUTICAL COMPOSITIONS CONTAINING IT, AND USE OF THEM
EA202091007A1 (en) METHOD FOR REDUCING RESTORATION TIME OF SPRAY-DRIED PROTEIN COMPOSITIONS
AR106482A1 (en) LIQUID DETERGENT COMPOSITION
MX2018014966A (en) Protease-resistant mono-lipidated peptides.
CL2018001680A1 (en) Compositions and methods of use of new strains of lactobacillus fermentum
IN2013DE01652A (en)
BR112018003714A8 (en) Weight increased acid compositions comprising amino acids
CL2018001026A1 (en) Applications of the protein vdal in the improvement of the yield, quality of the product and resistance to the drought of plants and in the promotion of the coloration of the fruits of the plant